CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding led by Cutlass Capital, JPMorgan Partners and
CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding led by Cutlass Capital, JPMorgan Partners and
Copyright PEI Media
Not for publication, email or dissemination